SCHEMBL19929705

SCHEMBL19929705

C#CCC(C)(CC#CC(O)C#Cc1ccccc1)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 2/20 0.41
HTT P42858 1/20 0.41
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
MMP2 P08253 6/20 0.35
MMP13 P45452 6/20 0.35
MMP3 P08254 5/20 0.35
MMP1 P03956 3/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAOB P27338 2/20 0.34
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929723 0.89 HTT (0.41) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19934088 0.88 ALDH1A1 (0.41) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19929707 0.84 HTT (0.37) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19929720 0.83 HTT (0.36) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19934062 0.80 ALDH1A1 (0.39) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19929700 0.79 ALDH1A1 (0.33) ALDH1A1CYP3A4
SCHEMBL19929726 0.79 HTT (0.34) ALDH1A1CYP3A4HTTMMP2MMP13
SCHEMBL19929736 0.77 CHRM2 (0.41) MAOBL3MBTL1
SCHEMBL19934148 0.76 HTT (0.38) ALDH1A1CYP3A4HTTCYP1A2MAPT
SCHEMBL19929740 0.76 ALDH1A1 (0.30) ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180065908-A1 CHAIN MULTIYNE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF XIAMEN UNIVERSITY (CN) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065908-A1 CHAIN MULTIYNE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF SQLE, COASY, MCCC2 ALDH1A1 761/4885CYP3A4 210/4885HTT 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.